These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26994397)

  • 1. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-Year Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Lokkerbol J; Rietdijk J; Dragt S; Klaassen RM; Kraan T; Boonstra N; Nieman DH; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2017 Mar; 43(2):365-374. PubMed ID: 27306315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial.
    van der Gaag M; Nieman DH; Rietdijk J; Dragt S; Ising HK; Klaassen RM; Koeter M; Cuijpers P; Wunderink L; Linszen DH
    Schizophr Bull; 2012 Nov; 38(6):1180-8. PubMed ID: 22941746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial.
    Rietdijk J; Dragt S; Klaassen R; Ising H; Nieman D; Wunderink L; Delespaul P; Cuijpers P; Linszen D; van der Gaag M
    Trials; 2010 Mar; 11():30. PubMed ID: 20307268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Kraan TC; Ising HK; Fokkema M; Velthorst E; van den Berg DPG; Kerkhoven M; Veling W; Smit F; Linszen DH; Nieman DH; Wunderink L; Boonstra N; Klaassen RMC; Dragt S; Rietdijk J; de Haan L; van der Gaag M
    Psychiatry Res; 2017 Jan; 247():55-62. PubMed ID: 27863320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.
    Reininghaus U; Klippel A; Steinhart H; Vaessen T; van Nierop M; Viechtbauer W; Batink T; Kasanova Z; van Aubel E; van Winkel R; Marcelis M; van Amelsvoort T; van der Gaag M; de Haan L; Myin-Germeys I
    Trials; 2019 Dec; 20(1):769. PubMed ID: 31878966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial.
    Ising HK; Smit F; Veling W; Rietdijk J; Dragt S; Klaassen RM; Savelsberg NS; Boonstra N; Nieman DH; Linszen DH; Wunderink L; van der Gaag M
    Psychol Med; 2015 May; 45(7):1435-46. PubMed ID: 25330734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
    Stain HJ; Bucci S; Baker AL; Carr V; Emsley R; Halpin S; Lewin T; Schall U; Clarke V; Crittenden K; Startup M
    Schizophr Res; 2016 Oct; 176(2-3):212-219. PubMed ID: 27554197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
    Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
    Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition and remission in adolescents at ultra-high risk for psychosis.
    Ziermans TB; Schothorst PF; Sprong M; van Engeland H
    Schizophr Res; 2011 Mar; 126(1-3):58-64. PubMed ID: 21095104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis.
    Wijnen BFM; Thielen FW; Konings S; Feenstra T; Van Der Gaag M; Veling W; De Haan L; Ising H; Hiligsmann M; Evers SMAA; Smit F; Lokkerbol J
    Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):269-279. PubMed ID: 31195900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.
    Morrison AP; French P; Walford L; Lewis SW; Kilcommons A; Green J; Parker S; Bentall RP
    Br J Psychiatry; 2004 Oct; 185():291-7. PubMed ID: 15458988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
    Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.